Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in the CLEOPATRA study

Abstract only 533^ Background: Addition of trastuzumab (T) to chemotherapy has transformed outcomes in pts with HER2-positive breast cancer. In pts who had received anthracyclines (A), T has been associated with cardiac dysfunction. Monitoring cardiac tolerability of anticancer drugs is important, i...

Full description

Bibliographic Details

Published in:	Journal of clinical oncology Vol. 30; no. 15_suppl; p. 533
Main Authors:	Ewer, Michael, Baselga, José, Clark, Emma, Benyunes, Mark, Ross, Graham, Swain, Sandra M.
Format:	Journal Article
Language:	English
Published:	20-05-2012
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!